筋骨痛消丸联合塞来昔布治疗膝骨关节炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R684.3

基金项目:


Clinical Study on Jingu Tongxiao Pills Combined with Celecoxib for Knee Osteoarthritis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察筋骨痛消丸联合塞来昔布对膝骨关节炎(KOA) 的临床疗效。方法:将86 例KOA 患 者随机分为研究组和对照组各43 例。对照组应用塞来昔布治疗,研究组在对照组基础上加用筋骨痛消丸治 疗。用药2 个月后,评估2 组临床疗效,比较2 组治疗前后中医证候积分、疼痛数字评价量表(NRS) 评分、 膝关节屈曲与伸直最大角度、血清白细胞介素-1β(IL-1β)、白细胞介素-7(IL-7)、成纤维细胞生长因子- 2(FGF-2) 水平。结果:治疗后,研究组总有效率为93.02%,对照组为67.44%,2 组比较,差异有统计学意 义(P<0.05)。治疗后,2 组中医证候积分、NRS 评分均较治疗前降低(P<0.05),且研究组中医证候积分、 NRS 评分均低于对照组(P<0.05)。治疗后,2 组血清IL-1β、IL-7 水平均较治疗前降低(P<0.05),FGF-2 水平均较治疗前升高(P<0.05);且研究组IL-1β、IL-7 水平低于对照组(P<0.05),FGF-2 水平高于对照 组(P<0.05)。治疗后,2 组膝关节屈曲、伸直最大角度均较治疗前增大(P<0.05),且研究组膝关节屈曲、 伸直最大角度均大于对照组(P<0.05)。结论:筋骨痛消丸联合塞来昔布治疗KOA 疗效优于单用塞来昔布治 疗,能显著改善患者临床症状,下调炎症因子水平,减轻关节损伤。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Jingu Tongxiao Pills combined with Celecoxib on knee osteoarthritis (KOA). Methods: A total of 86 cases of KOA patients were randomly divided into the study group and the control group, with 43 cases in each group. The control group was treated with Celecoxib,and the study group was additionally treated with Jingu Tongxiao Pills based on the treatment of the control group. After 2 months of medication, clinical effects were evaluated in the two groups; traditional Chinese medicine (TCM) syndrome scores,the Numerical Rating Scale (NRS),maximum angles of knee joint flexion and extension, and the levels of interleukin- 1β (IL- 1β), interleukin- 7 (IL- 7), and fibroblast growth factor- 2 (FGF- 2) in serum were compared between the two groups before and after treatment. Results:After treatment,the total effective rate was 93.02% in the study group and 67.44% in the control group,the difference being significant (P<0.05). After treatment,TCM syndrome scores and NRS scores in the two groups were decreased when compared with those before treatment (P<0.05),and TCM syndrome score and NRS score in the study group were lower than those in the control group (P< 0.05). After treatment,the levels of IL-1β and IL-7 in the two groups were decreased when compared with those before treatment (P<0.05), and the levels of FGF- 2 were increased when compared with those before treatment (P<0.05);the levels of IL-1β and IL-7 in the study group were lower than those in the control group (P<0.05),and the level of FGF-2 in the study group was higher than that in the control group (P<0.05). After treatment,the maximum angles of knee joint flexion and extension in the two groups were increased when compared with those before treatment (P<0.05),and the maximum angles of knee joint flexion and extension in the study group were larger than those in the control group (P<0.05). Conclusion: Jingu Tongxiao Pills combined with Celecoxib have better curative effect than the simple application of Celecoxib in the treatment of KOA,and can significantly improve clinical symptoms,down- regulate the levels of inflammatory factors,and reduce joint damage.

    参考文献
    相似文献
    引证文献
引用本文

李俊业,王冲,赵振杰.筋骨痛消丸联合塞来昔布治疗膝骨关节炎临床研究[J].新中医,2023,55(24):96-100

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-12-30
  • 出版日期:
文章二维码